Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Oncotarget. 2016 Nov 22;7(47):78219. doi: 10.18632/oncotarget.13482.
No abstract available

Publication types

  • Published Erratum